# Lifyorli

NDC: 76346-425
Generic name: Relacorilant
Labeler / Manufacturer: Corcept Therapeutics Incorporated
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: KIT
Routes: ORAL
Marketing started: 20260325

FDA application: NDA220641

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76346-425"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76346-425
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6fcebfb5-19d6-4f63-b852-999d68a13729